Seroepidemiological surveillance of antibodies to sars-cov 2 in before - and post-vaccinal period of emergency vaccinoprovention of covid-19 under pandemic conditions
Kurbanov Botirjon JurabayevichDeputy Head of the Service of Sanitary and Epidemiological Welfare and Public Health of the Republic of UzbekistanYusupaliev Bakhodir KakhramonovichDoctor of Medical Sciences, Head of the Service of Sanitary and Epidemiological Welfare and Public Health of the Republic of UzbekistanBektimirov Amir Mangu-TemirovichCandidate of Medical Sciences, Senior Researcher, Head of the Laboratory of Microbiology of the Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic DiseasesAkhmedova Khalida YuldashevnaDoctor of Medical Sciences, Deputy Director of the Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic DiseasesKosimov Odil ShodievichDoctor of Medical Sciences, Scientific Secretary of the Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic DiseasesAnvarova Latofat UsmanovnaDoctor of Medical Sciences, Head of the Department for Innovation and Training in Science of the Service of Sanitary and Epidemiological Wellbeing and Public Health of the Republic of UzbekistanAbdurahimova Zulfiya Kudratullaevna
ABI
Аннотация
Coronavirus SARS-CoV-2, the causative agent of COVID-19, has caused a still evolving global pandemic. Given the worldwide vaccination campaign - understanding vaccine-induced immunity and COVID-19-induced immunity will help adjust vaccine dosing strategies and accelerate vaccination efforts. There is some evidence of a decrease in antibody titers, which is an axiom of any vaccine administration, not equal to a decrease in cellular immunity.
Ҳали таржима қилинмаган
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос0 та фойдаланилган манба